{"id":437,"date":"2021-01-05T15:07:04","date_gmt":"2021-01-05T22:07:04","guid":{"rendered":"https:\/\/neurotucson.fm1.dev\/neurology\/recurrent-and-newly-diagnosed-glioblastoma\/"},"modified":"2021-03-31T10:49:42","modified_gmt":"2021-03-31T16:49:42","slug":"recurrent-and-newly-diagnosed-glioblastoma","status":"publish","type":"page","link":"https:\/\/neurotucson.com\/neurology\/clinical-research\/recurrent-and-newly-diagnosed-glioblastoma\/","title":{"rendered":"Recurrent and Newly Diagnosed Glioblastoma"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Recurrent and Newly Diagnosed Glioblastoma: BeiGene BGB-290 Study<\/h2>\n\n\n\n<p>This study is to evaluate the safety, efficacy and clinical activity of BGB-290 in combination with radiation therapy (RT) and\/or temozolomide (TMZ) in subjects with newly diagnosed or recurrent\/refractory glioblastoma.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Study Enrollment<\/h2>\n\n\n\n<p>If you, your family member or loved one is interested in learning more about participating in this study, please contact the BeiGene Study Coordinator at <br><a href=\"tel:+15203202157\">520-320-2157<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recurrent and Newly Diagnosed Glioblastoma: BeiGene BGB-290 Study This study is to evaluate the safety, efficacy and clinical activity of BGB-290 in combination with radiation therapy (RT) and\/or temozolomide (TMZ) in subjects with newly diagnosed or recurrent\/refractory glioblastoma. Study Enrollment If you, your family member or loved one is interested in learning more about participating&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":446,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","schema":"","fname":"","lname":"","position":"","credentials":"","placeID":"","no_match":false,"name":"","company":"","review":"","address":"","city":"","state":"","zip":"","lat":"","lng":"","phone1":"","phone2":"","fax":"","mon1":"","mon2":"","tue1":"","tue2":"","wed1":"","wed2":"","thu1":"","thu2":"","fri1":"","fri2":"","sat1":"","sat2":"","sun1":"","sun2":"","hours-note":"","footnotes":""},"service_tags":[],"class_list":["post-437","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/pages\/437"}],"collection":[{"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/comments?post=437"}],"version-history":[{"count":4,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/pages\/437\/revisions"}],"predecessor-version":[{"id":1602,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/pages\/437\/revisions\/1602"}],"up":[{"embeddable":true,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/pages\/446"}],"wp:attachment":[{"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/media?parent=437"}],"wp:term":[{"taxonomy":"service_tags","embeddable":true,"href":"https:\/\/neurotucson.com\/wp-json\/wp\/v2\/service_tags?post=437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}